Predictive strength of Jonckheere's test for trend: an application to genotypic scores in HIV infection
- 30 March 2007
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 26 (24) , 4441-4454
Abstract
A problem arising in studies on the human immunodeficiency virus (HIV) infection relate to one-sided tests with ordered alternatives as opposed to the more classical two-sided tests. Patients not having a resistance mutation may have a better virologic response to treatment than patients with a single mutation. In turn, those with a single mutation may have a better response to treatment than those patients having two mutations, and so on. In the presence of a continuous outcome, Jonckheere's test for ordered alternatives is well adapted to this situation. Such an analysis does not provide any measure of prediction or explained variation which can complement these results. A measure of strength of effect would be helpful in quantifying the degree of association between the genotypic score (number of mutations) and some continuous virological response. We suggest a simple measure of ‘goodness of split’ for Jonckheere's test for trend. Interestingly, the measure can be related to the non-parametric measure of association known as gamma. The variance formula for the measure studied here can be seen to differ from the known variance estimate of the gamma measure, and simulations show it to be more accurate. Expectation and variance under H0 of the measure are provided and a large simulation study is presented. Methods are applied to a recent clinical data set involving HIV-1 infected patients where the number of resistance mutations are investigated as potential predictors of the amount of HIV-1 RNA reduction at week 4. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Clinically Relevant Genotype Interpretation of Resistance to DidanosineAntimicrobial Agents and Chemotherapy, 2005
- Didanosine in HIV‐1–Infected Patients Experiencing Failure of Antiretroviral Therapy: A Randomized Placebo‐Controlled TrialThe Journal of Infectious Diseases, 2005
- Prentice's Approach and the Meta‐Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate EndpointsBiometrics, 2004
- Clinically relevant interpretation of genotype for resistance to abacavirAIDS, 2003
- European guidelines for the clinical management and treatment of HIV-infected adults in EuropeAIDS, 2003
- On the Use of Magnitude of Reduction in HIV-1 RNA in Clinical Trials: Statistical Analysis and Potential BiasesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Testing Against Ordered Alternatives for Censored Survival DataJournal of the American Statistical Association, 1993
- Measures of dependence for censored survival dataBiometrika, 1988
- Measures of Association for Cross Classifications, IV: Simplification of Asymptotic VariancesJournal of the American Statistical Association, 1972
- A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVESBiometrika, 1954